NSEShareholders meeting1h ago · 25 Sept 2026, 06:21 pm

Shareholders meeting

Bal Pharma Limited · BALPHARMA

✦ AI Summaryshareholders_meeting

Bal Pharma Limited has submitted the Exchange a copy of the Scrutinizer's report of the 39th Annual General Meeting held on September 24, 2026, and informed the Exchange regarding voting results.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Bal Pharma Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 24, 2026. Further, the company has informed the Exchange regarding voting results.

Attachments (1)

📄

BALPHARMA1_25092026182050_Result_Final.pdf

pdf

Download →
View document text
To To Date: September 25, 2026 Listing Compliance Department BSE Limited National Stock Exchange of India Limited, 1st Floor, New Trading Exchange Plaza, 5th Floor, Plot No. C/2, G Ring, Block, Rotunda Building, P.J. Bandra Kurla Complex, Bandra (E), Towers, Mumbai-400051 Dalal Street, Mumbai – 400001 Symbol: BALPHARMA Scrip Code: 524824 Sub: Voting Results and Scrutinizer’s Report of the 39th Annual General Meeting (AGM): Pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014, as amended from time to time, we hereby submit the following documents in respect of the 39th Annual General Meeting (“AGM”) of the Company held on September 24, 2026 at 11:30 A.M. through Video Conferencing/Other Audio-Visual Means (“VC/OAVM”): 1. Consolidated Voting Results of the resolutions passed at the 39th AGM, as declared by Mr. Shailesh Siroya, Managing Director of the Company; and 2. Scrutinizer’s Report submitted by Mr. Parameshwar Bhat, Practicing Company Secretary (Membership No. 11004), on the resolutions set forth in the AGM Notice dated August 12, 2026 convening the 39th AGM. The aforesaid Voting Results and Scrutinizer’s Report are also being made available on the website of the Company at www.balpharma.com. You are requested to kindly take the above submission on record. Thanking You. For Bal Pharma Limited Shreepada ML Company Secretary and Compliance officer ICSI M No : A66681 Enclosure: As above DECLARATION OF VOTING RESULTS OF THE RESOLUTIONS PASSED THROUGH REMOTE E-VOTING AND E-VOTING DURING THE 39TH ANNUAL GENERAL MEETING OF BAL PHARMA LIMITED HELD ON 24TH SEPTEMBER, 2026 AT 11:30 A.M. THROUGH VIDEO CONFERENCING / OTHER AUDIO-VISUAL MEANS (“VC/OAVM”) Dear Members, We hereby declare the consolidated voting results in respect of the resolutions considered and passed at the 39th Annual General Meeting (“AGM”) of Bal Pharma Limited (“the Company”), held on 24th September, 2026 at 11:30 A.M. through Video Conferencing / Other Audio-Visual Means (“VC/OAVM”), based on the Consolidated Scrutinizer’s Report submitted by Mr. Parameshwar Bhat, Practicing Company Secretary (M. No. 11004). The Company had provided its members with the facility to cast their votes through remote e- voting from 21st September, 2026 at 9:00 A.M. (IST) to 23rd September, 2026 at 5:00 P.M. (IST). The Company also provided the facility of e-voting during the AGM to those Members who were present at the AGM through VC/OAVM and had not cast their votes through remote e-voting. The Board of Directors of the Company had appointed Mr. Parameshwar Bhat, Practicing Company Secretary (M. No. 11004), as the Scrutinizer to scrutinize the remote e-voting process and the e-voting conducted during the AGM in a fair and transparent manner. The Scrutinizer submitted his Consolidated Report dated 24th September, 2026, containing the results of the remote e-voting and e-voting conducted during the AGM. Based on the Consolidated Scrutinizer’s Report, the voting results in respect of the resolutions considered at the 39th AGM are as follows: Resolution %age of %age of Srl Type votes Particulars votes cast No. (Ordinary/ cast in in favour Special) against 1 To receive, consider and adopt the Audited Standalone and Consolidated Financial Ordinary Statements of the Company for the financial year Resolution ended March 31, 2026, together with the Reports 100 0* of the Board of Directors and the Auditors thereon. Ordinary To declare dividend of Rs. 1.20 per equity share 2 Resolution 100 0* of Rs. 10/- each for the Financial Year 2025-26. 3 To re-appoint Mr. Ravindra Kumar Kothari (DIN: 03418320), who retires by rotation, as a Director Ordinary 99.75 0.25 of the Company. Resolution 4 To ratify the remuneration payable to the Cost Ordinary Auditors for the Financial Year 2026-27. 100 0* Resolution 5 To renew the contract with M/s. Desa Marketing Ordinary International. 99.44 0.56 Resolution 6 To approve the change in designation of Mr. Ravindra Kumar Kothari (DIN: 03418320) from Special 99.75 0.25 Non-Executive Director to Whole-Time Director. Resolution 7 To approve the change in designation of Mr. Virupakshaya Himesh (DIN: 08554422) from Special 100 0* Whole-Time Director to Non-Executive Director. Resolution * Negligible Based on the Consolidated Scrutinizer’s Report, all the aforesaid resolutions were duly passed by the Members at the 39th Annual General Meeting with the requisite majority. The detailed voting results, as required under the applicable provisions of the Companies Act, 2013 and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 enclosed herewith. Thanking you. Yours faithfully, For Bal Pharma Limited Shailesh Siroya Managing Director DIN: 00048109 Enclosure: As above PARAMESHWAR G. BHAT # 496/4, II Floor, 10th Cross B.Com., LLB, ML, MBA, FCS Near Bashyam Circle, Sadashivanagar, Bangalore - 560 080 Company Secretary Tel : +91 80 23610847 Telefax : +91 80 41231106 e-mail ; parameshwar@vijkt.in parameshwar.g.bhat@gmail.com SCRUTINIZER’S REPORT [Pursuant to Sections 108 & 109 of the Companies Act, 2013 and the Companies (Management & Administration) Rules, 2014] {Private & Confidential} {Strictly to the addressee only} Mr. Shailesh Siroya Managing Director & Chairman of the 39" Annual General Meeting Bal Pharma Limited Bengaluru Dear Sir, |, Parameshwar G Bhat, Practicing Company Secretary (Membership No. FCS 8860, CP No. 11004), having office at # 496/4, 2™ Floor, 10” Cross, Near Bashyam Circle, Sadashivanagar, Bengaluru - 560 080, duly appointed as Scrutinizer by Bal Pharma Limited (‘the Company’) for the purpose of scrutinizing the e-voting prior to the Annual General Meeting (‘remote e-voting’) and electronic voting (‘e-voting) at the 39° Annual General Meeting (AGM) held on Thursday, 24! day of September, 2026 at 11:30 A.M (held through Video Conferencing (‘VC’VOther Audio Visual Means (OAVM’}), pursuant to Sections 108 and 109 of the Companies Act, 2013 (the Act), read with Rules 20 and 21 of the Companies (Management & Administration) Rules, 2014 (the Rules) as amended from time to time and the provisions of Regulation 44 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘the Listing Regulations’), hereby furnish my Report to you. The notice dated 12" day of August, 2026 as confirmed by the Company was sent to the Shareholders on 26' day of August, 2026 in respect of the below mentioned resolutions passed at the AGM of the Company, in compliance with the Ministry of Corporate Affairs (MCA) General Circulars namely Circular No.19/2021 dated December 8, 2021 read with Circular No.14/2020 dated April 8, 2020, Circular No.17/2020 dated April 13, 2020, Circular No. 20/2020 dated May 5, 2020, Circular No. 02/2021 dated January 13, 2021, Circular No. 03/2022 dated May 5, 2022, General Circular No. 11/2022 dated December 28, 2022, General Circular No. 09/2024 dated September 19, 2024 and read with other 8860 P-11004 relevant circulars issued in this regard the latest being General Circular No. 03/2025 dated September 22, 2025 (collectively referred to as "MCA Circulars") and SEB| Circulars dated 12" May, 2020, 15tn January, 2021,13! May, 2022, 25'" September, 2023 and 3 October, 2024 issued by the Securities and Exchange Board of India (collectively referred to as ‘SEBI Circulars’) permitted the holding of the Annual General Meeting (‘AGM’) through VC/OAVM, without the physical presence of the Members. The Management of the Company is responsible to ensure compliance of the requirements of the Companies Act, 2013 and Rules made there under relating to voting through remote e-voting and e-voting at the Annual General Meeting for the resolutions proposed in the Notice of 39" Annual General Meeting. My responsibility as a Scrutinizer is to en [Showing first 8,000 characters — download PDF for full document]